Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective studyShuhei Hara, Takahiro Kimura, Eriko Nishi et al.|International Journal of Clinical Oncology|2024Cited by 9
The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiationSoshi Kadena, Takahiro Kimura, Fumihiko Urabe et al.|International Journal of Clinical Oncology|2023Cited by 7
Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancerKeiichiro Miyajima, Takahiro Kimura, Hirotaka Suzuki et al.|International Journal of Clinical Oncology|2023Cited by 4
Presurgical immune-oncology/tyrosine kinase inhibitor combination therapy for renal cell carcinoma with a vena cava tumor thrombus: a single-institution case seriesFumihiko Urabe, Takahiro Kimura, Kosuke Iwatani et al.|Translational Andrology and Urology|2023Cited by 4
Clinical Significance of Intraductal Carcinoma of the Prostate After High-Dose Brachytherapy With External Beam Radiation Therapy: A Single Institution Series and an Updated Meta-AnalysisKeiichiro Miyajima, Takahiro Kimura, Shun Sato et al.|Clinical Genitourinary Cancer|2023Cited by 3